Nifedipine GITS

DRUG3 trials

Sponsors

Istituto Auxologico Italiano, Peking University First Hospital, Jing Liu

Conditions

High Blood Pressure VariabilityHypertension

Phase 4

REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial

CompletedNCT02499822

Istituto Auxologico ItalianoHigh Blood Pressure Variability, Hypertension

Start: 2015-10-31End: 2020-11-01Updated: 2021-09-30

Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension

Peking University First HospitalHypertension

Start: 2015-10-31End: 2019-12-31Target: 700Updated: 2019-03-22

Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness

TerminatedNCT02940548

Jing LiuHypertension

Start: 2016-12-31End: 2020-12-31Updated: 2022-04-29

Related Papers

A Randomized Controlled Trial on the Efficacy and Safety of a Calcium-Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor in Chinese and European Patients with Hypertension

American Journal of Hypertension2024-12-091 citations

A comparative study for the effects of nifedipine GITS and amlodipine besylate administrated in daytime or at nighttime on recovery of blood pressure rhythm and arterial stiffness in the young and middle‐aged subjects with non‐dipper hypertension (NARRAS): Design and rationale

International Journal of Clinical Practice2020-07-293 citations